[Federal Register Volume 76, Number 142 (Monday, July 25, 2011)]
[Notices]
[Pages 44338-44339]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-18755]



-----------------------------------------------------------------------



DEPARTMENT OF HEALTH AND HUMAN SERVICES



Centers for Disease Control and Prevention



[Docket Number NIOSH-245]




Notice of Public Meeting on the NIOSH Document Titled: ``Criteria 

for a Recommended Standard: Occupational Exposure to Diacetyl and 2,3-

pentanedione''



AGENCY: National Institute for Occupational Safety and Health (NIOSH), 

Centers for Disease Control and Prevention (CDC), Department of Health 

and Human Services (HHS).



ACTION: Notice of public meeting.



-----------------------------------------------------------------------



SUMMARY: The National Institute for Occupational Safety and Health 

(NIOSH) of the Centers for Disease Control and Prevention (CDC) will 

hold a public meeting to discuss and obtain comments on the draft 

document, ``Criteria for a Recommended Standard: Occupational Exposure 

to Diacetyl and 2,3-pentanedione''. A copy of the draft document will 

be posted on the Internet at http://www.cdc.gov/niosh/docket/review/docket245/default.html for Docket number NIOSH-245 on August 12, 2011. 

This notice serves as advance notice of the meeting and public comment 

period.



Table of Contents



Date and Time

Address

Status

Speaker Registration

Agenda

Supplementary Information

    I. Matters to Be Discussed

    II. Transcripts

    III. Public Comment Period

Contact Person for More Information





DATES and Time:  August 26, 2011, 8 a.m.-4 p.m., Eastern Time. Please 

note that public comments may end before the time indicated, following 

the last call for comments. Members of the public who wish to provide 

comments should plan to attend the meeting at the start time listed.



ADDRESSES: Omni Shoreham, 2500 Calvert, Street NW. (at Connecticut 

Avenue) Washington, DC 20008.

    Status: The meeting is open to the public limited only by the space 

available. The meeting room accommodates 150 people. To pre-register 

for the meeting, interested parties should contact the NIOSH Docket 

Office at nioshdocket@cdc.gov or by fax at (513) 533-8285. Due to 

limited space, notification of intent to attend the meeting must be 

made to the NIOSH Docket Office no later than August 19, 2011. Priority 

for attendance will be given to those providing oral comments. Other 

requests to attend the meeting will then be accommodated on a first-

come basis.

    Speaker Registration: Persons wanting to provide oral comments on 

the draft document should contact the NIOSH Docket Office at 

nioshdocket@cdc.gov or by fax at (513) 533-8285. Presenters will be 

permitted approximately 10 minutes, and will be informed if additional 

time becomes available. All requests to present should contain the 

name, address, telephone number, and relevant business affiliations of 

the presenter, and the topic of the presentation. Oral comments made at 

the public meeting must also be submitted to the NIOSH Docket Office in 

writing in order to be considered by the Agency.

    Agenda: The meeting will begin with an introduction and 

presentation by Federal officials, followed by presentations from 

attendees who register to speak. Each speaker will be limited to ten 

minutes. If all pre-registered presentations are complete before the 

end time, there will be an open session to receive comments from anyone 

who has not signed up on the speaker registration list who may wish to 

speak. Open session comments will also be limited to 10 minutes per 

speaker. After the last speaker or at 4 p.m., whichever occurs first, 

the meeting will be adjourned.



SUPPLEMENTARY INFORMATION: 



I. Matters To Be Discussed



    At the public meeting, special emphasis will be placed on the 

following topics:

    1. Hazard identification, risk estimation, and discussion of health 

effects for diacetyl and 2,3-pentanedione;

    2. Basis of the Recommended Exposure Limit for diacetyl and 2,3-

pentanedione;

    3. Workplaces and occupations where exposure to diacetyl and 2,3-

pentanedione occur;

    4. Current exposure measurement methods;

    5. Current strategies for controlling occupational exposure to 

diacetyl and 2,3-pentanedione: e.g., engineering controls, work 

practices, medical surveillance, and personal protective equipment;

    6. Oral comments provided to NIOSH on the draft criteria document.



II. Transcripts



    Transcripts will be prepared and posted to NIOSH Docket number 245 

approximately 30 days after the meeting. If a person making a comment 

gives his or her name, no attempt will be made to redact that name. 

NIOSH will take reasonable steps to ensure that individuals making 

public comments are aware of the fact that their comments (including 

their name, if provided) will appear in a transcript of the meeting 

posted on a public Web site. Such reasonable steps include: (a) A 

statement read at the start of the meeting stating that transcripts 

will be posted and names of speakers will not be redacted; and (b) A 

printed copy of the statement mentioned in (a) above will be displayed 

on the table where individuals sign up to make public comments. If 

individuals in making a statement reveal personal information (e.g., 

medical information) about



[[Page 44339]]



themselves, that information will not usually be redacted. The CDC 

Freedom of Information Act coordinator will, however, review such 

revelations in accordance with the Freedom of Information Act and if 

deemed appropriate, will redact such information. Disclosures of 

information concerning third parties will be redacted.



III. Public Comment Period



    Written comments on the document will be accepted until October 14, 

2011 in accordance with the instructions below. All material submitted 

to NIOSH should reference Docket Number NIOSH-245. All electronic 

comments should be formatted as Microsoft Word or pdf files and make 

reference to docket number NIOSH-245. To submit comments, please use 

one of these options:

     Present oral comments at the public meeting and provide a 

written copy of comments to the NIOSH Docket Office.

     Send NIOSH comments using the online form at http://www.cdc.gov/niosh/docket/review/docket245/comments.html.

     Send comments by e-mail to 

nioshdocket@cdc.gov?subject=245.

     Facsimile: (513) 533-8285.

     Mail: NIOSH Docket Office, Robert A. Taft Laboratories, 

MS-C34 4676 Columbia Parkway, Cincinnati, Ohio 45226.

    All information received in response to this notice will be 

available for public examination and copying at, NIOSH Docket Office, 

4676 Columbia Parkway, Room 111, Cincinnati, Ohio 45226. A complete 

electronic docket containing all comments submitted will be available 

on the NIOSH docket home page at http://www.cdc.gov/niosh/docket/, and 

comments will be available in writing by request. NIOSH includes all 

comments received without change in the docket, including any personal 

information provided.



CONTACT PERSON FOR MORE INFORMATION: Lauralynn Taylor McKernan, ScD, 

CIH, NIOSH, 4676 Columbia Parkway, MS-C32, Cincinnati, OH 45226, 

telephone (513) 533-8542, fax (513) 533-8230, E-mail LMcKernan@cdc.gov.



    Dated: July 19, 2011.

John Howard,

Director, National Institute for Occupational Safety and Health, 

Centers for Disease Control and Prevention.

[FR Doc. 2011-18755 Filed 7-22-11; 8:45 am]

BILLING CODE 4163-19-P